MEDIA ADVISORY
ATTENTION HEALTH AND
MEDICAL REPORTERS
A Medical News
Special Report
METABOLIFE RENEWS
ITS CALL FOR STRONG FDA REGULATION OF EPHEDRA
COMPANY TELLS
SENATE GOVERNMENT AFFAIRS SUBCOMMITTEE
THAT METABOLIFE
356 IS SAFE AND EFFECTIVE WHEN USED AS DIRECTED
WHO: SENATE GOVERNMENTAL AFFAIRS
COMMITTEE, Oversight of Government Management, Restructuring and the District of
Columbia Subcommittee
WHAT: EPHEDRA OVERSIGHT HEARING
WHEN:
TUESDAY, OCTOBER 8, 2002
WHY: OBESITY HAS REACHED EPIDEMIC PROPORTIONS. MORE THAN 25% OF
ADULTS ARE OVERWEIGHT AND OBESE. BEING OVERWEIGHT AND OBSE ARE MAJOR HEALTH
RISKS TO AMERICANS.
THE APRIL 25, 2002 EDITION OF
PRESTIGIOUS INTERNATIONAL JOURNAL OF OBESITY, PUBLISHED A LONG-TERM
CLINICAL TRIAL OF EPHEDRA CONDUCTED BY RESEARCHERS AT COLUMBIA UNIVERSITY
AND HARVARD MEDICAL SCHOOL. THE RESEARCHERS CONCLUDED THAT “HERBAL EPHEDRA/CAFFEINE
PROMOTED BODY WEIGHT AND BODY FAT REJECTION AND IMPROVED BLOOD LIPIDS WITHOUT
SIGNIFICANT ADVERSE EVENTS.”
EXPERTS AGREE THAT SIGNIFICANT
HEALTH BENEFITS MAY BE OBTAINED BY A 5-10% WEIGHT LOSS. METABOLIFE 356 IS SAFE
AND EFFECTIVE WHEN USED AS DIRECTED.
METABOLIFE WOULD WELCOME THE OPPORTUNITY TO DISCUSS THIS
ISSUE WITH YOU. FOR MORE INFORMATION AND INTERVIEWS CONTACT JAN STRODE,
619.890.4040